Intelligent Bio Solutions Inc. INBS 深 滬
等待開盤 02-05 09:30:00 美东时间
6.955
-0.455
-6.14%
華盛通- 最 高7.325
- 今 開7.20
- 成交量 14.20万股
- 最 低 6.66
- 昨 收 7.41
- 總市值 667.33万
- 52周最高 27.50
- 市盈率 靜 --
- 換手率 14.80%
- 52周最低 4.03
- 委 比 98.02%
- 總股本 95.95万
- 歷史最高 34176.00
- 量 比 1.32
- 振 幅 8.97%
- 歷史最低 5.38
- 每 手 1
- 風險率 4.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
Intelligent Bio Solutions Inc. has launched a clinical study program to support its FDA 510(k) application for the U.S. market clearance of its fingerprint-based drug screening system for detecting codeine. Partnering with Cliantha Research, the first study will enroll 40 adults to establish optimal detection thresholds, with results expected by March 2026. The U.S. drug screening market, valued at several billion dollars annually, presents a sig...
01-28 13:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers NovaBay Pharmaceuticals (AMEX:NBY) stock rose 36.9% to $12.95 during F...
01-10 01:05
Intelligent Bio Solutions Regains Nasdaq Listing Compliance Status
An update from Intelligent Bio Solutions ( ($INBS) ) is now available. On Janua...
01-09 06:29
Intelligent Bio Solutions Announces Strategic Manufacturing Partnership With Syrma Johari MedTech, To Support And Scale The Production Of Its Intelligent Fingerprinting Drug Screening Reader; Anticipates Annual Production Cost Savings Of More Than 40%, Translating To An Expected Improvement Of ~20 Percentage Points In Gross Margin Compared With Its Previous Manufacturing Arrangement
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new strategic manufacturing
2025-12-31 21:47
Intelligent Bio Solutions Partners With Vlepis To Tap Consumer Health Monitoring Market
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has entered into a non-exclusive
2025-12-18 21:35
Intelligent Bio Solutions Announces 1-For-10 Reverse Split, Effective December 15
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("Intelligent Bio Solutions" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it
2025-12-12 23:33
Intelligent Bio Solutions Q1 EPS $(0.35) Up From $(0.70) YoY, Sales $1.112M Up From $872.287K YoY
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.35) per share. This is a 50 percent increase over losses of $(0.70) per share from the same period last year. The company reported $1.112 million
2025-11-12 21:37
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
Intelligent Bio Solutions Inc. reported a 50% increase in new customer accounts during its fiscal first quarter of 2025, reaching over 480 active accounts. Key growth sectors include maritime, transportation, logistics, electrical and electronic manufacturing, construction, and government administration, with the latter being a new entry. The UK market showed strong expansion, with 91% of new accounts being first-time adopters. The company's fing...
2025-10-30 12:30
